Impaired Contact Hypersensitivity Reaction and Reduced Production of Vascular Endothelial Growth Factor in Tumor Necrosis Factor‐α Gene‐Deficient Mice

Tumor necrosis factor (TNF)‐α is an important proinflammatory cytokine in contact hypersensitivity (CHS) reactions. Previous efforts to assay CHS in TNF‐α gene‐deficient (‐/‐) mice have demonstrated a significant reduction in ear skin weight at 24 h following challenge by oxazolone, although the mechanisms of this suppression have not been examined. To further characterize the impaired CHS during evolution of the elicitation phase in TNF‐α ‐/‐ mice and to clarify its mechanisms, focusing on the roles of TNF‐α and vascular endothelial growth factor (VEGF), we used an established method of CHS assay‐sensitization and challenge by trinitrochlorobenzene (TNCB)‐ in TNF‐α ‐/‐ and wild‐type mice. We compared the histopathology of the sequential evolution of CHS between the two groups of mice and assessed both the extent of inflammatory cell infiltration and the degree of dilatation in dermal vessels labeled with CD31. We quantified the production of VEGF in the epidermis at specific time points by using a murine VEGF ELISA kit. The CHS reaction was markedly suppressed in TNF‐α ‐/‐ mice at all time points of the elicitation phase. Histologically, in TNF‐α ‐/‐ mice we observed diminished vascular permeability, reduced numbers of infiltrating inflammatory cells, neutrophils at 12 h, mononuclear cells and eosinophils at 24 h, and a decreased area of dilatation of vessels labeled with CD31. The level of epidermal VEGF in wild type mice increased rapidly after challenge and peaked at 24 h, paralleling the peak of ear swelling. In contrast, the peak level of epidermal VEGF in TNF‐α ‐/‐ mice was significantly reduced. These results suggest that TNF‐α plays an enhancing role in the elicitation phase of the CHS reaction. Diminished degrees of vascular permeability, dilatation of CD31+ vessels, and inflammatory cell infiltration in TNF‐α ‐/‐ mice are likely to be the result of a lack of TNF‐α and reduced production of epidermal VEGF.